Fund Holdings — Redmile Group, LLC

Total Portfolio Value
$1.51B
Total Bought
$305.43M
Total Sold
$155.74M
Net Transaction
+$149.69M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SCHOLAR ROCK HLDG CORP(SRRK)5,220,8469,066,621+3,845,775229,978445,71529.51%+215,737
ANNEXON INC(ANNX)10,050,64414,549,768+4,499,12450,45480,6065.34%+30,151
SHATTUCK LABS INC(STTK)5,539,7245,539,724020,22035,6202.36%+15,400
ALX ONCOLOGY HLDGS INC(ALXO)3,264,7187,964,188+4,699,4703,68915,9681.06%+12,279
BIOMARIN PHARMACEUTICAL INC(BMRN)0173,859+173,85909,8210.65%+9,821
XENON PHARMACEUTICALS INC(XENE)133,882262,674+128,7926,00115,2741.01%+9,274
STOKE THERAPEUTICS INC(STOK)4,034,0704,164,120+130,050128,041135,5848.98%+7,542
KRYSTAL BIOTECH INC(KRYS)677,705673,505-4,200167,081173,98011.52%+6,898
PRIME MEDICINE INC(PRME)01,590,832+1,590,83205,5360.37%+5,536
EUPRAXIA PHARMACEUTICALS INC(EPRX)0700,000+700,00005,0680.34%+5,068
ARDELYX INC0733,350+733,35004,3930.29%+4,393
SOLID BIOSCIENCES INC1,860,5422,011,895+151,35310,49314,4860.96%+3,992
FATE THERAPEUTICS INC(FATE)12,872,94612,872,946012,64915,4481.02%+2,799
ADC THERAPEUTICS SA(ADCT)15,666,73115,470,502-196,22955,30458,0143.84%+2,711
AGOMAB THERAPEUTICS NV(AGMB)0156,250+156,25001,6390.11%+1,639
ORIC PHARMACEUTICALS INC(ORIC)448,110415,710-32,4003,6665,2670.35%+1,602
CELLDEX THERAPEUTICS INC NEW(CLDX)283,308261,508-21,8007,6958,2950.55%+600
DBV TECHNOLOGIES S A(DBVT)549,840491,340-58,50010,54010,2640.68%-276
LIVANOVA PLC(LIVN)118,054108,354-9,7007,2646,8870.46%-377
ZYMEWORKS INC(ZYME)491,654491,654012,94512,3110.82%-634
NEUROGENE INC(NGNE)1,459,5991,459,599030,06829,4261.95%-642
KALARIS THERAPEUTICS INC(KLRS)82,9550-82,9557000—-700
PLIANT THERAPEUTICS INC(PLRX)1,616,228772,126-844,1021,9729730.06%-999
IMMUNOME INC(IMNM)5,718,3855,558,885-159,500122,831121,5738.05%-1,258
SILENCE THERAPEUTICS PLC(SLN)2,164,7772,164,777013,16211,4080.76%-1,753
ESTABLISHMENT LABS HLDGS INC(ESTA)112,664103,464-9,2008,2115,8750.39%-2,336
CERIBELL INC(CBLL)435,239386,786-48,4539,5457,0900.47%-2,455
INVIVYD INC(IVVD)2,681,1592,648,659-32,5006,6223,4430.23%-3,179
ABSCI CORPORATION8,253,3168,253,316028,80424,7601.64%-4,044
REPARE THERAPEUTICS INC1,586,1740-1,586,1744,1240—-4,124
ATARA BIOTHERAPEUTICS INC441,701441,70107,9902,0890.14%-5,901
BEAM THERAPEUTICS INC(BEAM)1,285,8591,237,659-48,20035,64429,4931.95%-6,151
IDEAYA BIOSCIENCES INC(IDYA)742,017521,117-220,90025,65217,3641.15%-8,288
REPLIMUNE GROUP INC(REPL)1,099,7560-1,099,75610,6900—-10,690
NUVATION BIO INC(NUVB)3,163,2563,153,256-10,00028,34313,5270.90%-14,815
COGENT BIOSCIENCES INC(COGT)1,437,918688,036-749,88251,07526,4831.75%-24,592
REGENXBIO INC(RGNX)4,368,8044,368,804062,91136,6112.42%-26,300
RAPT THERAPEUTICS INC885,9270-885,92730,0060—-30,006
NURIX THERAPEUTICS INC(NRIX)8,093,9087,732,808-361,100153,541119,8597.94%-33,683
Page 1 of 1
Redmile Group, LLC — 13F Holdings — Q1 2026 | TickerTrail